New technology discovery holds promise for improved breast cancer treatment

Feb 01, 2009

In a study published by Nature Biotechnology online on February 1, 2009, Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumours to determine a patient's best treatment options. The tool can predict with more than 80 per cent accuracy a patient's chance of recovering from breast cancer.

"Breast cancer is the most common cancer in Canadian women," said Dr. Jeff Wrana, Senior Investigator and the Mary Janigan Research Chair in Molecular Cancer Therapeutics at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, and an International Scholar of the Howard Hughes Medical Institute. "Our hope with this technology is to eventually provide individualized analysis to breast cancer patients and their oncologists so that they are better informed and empowered to select a treatment best suited to them."

The technology, called 'DyNeMo' analyzes networks of proteins in cancer cells. Analysis of more than 350 patients found that those who survive breast cancer have a different organization of the network of proteins within the tumour cells, compared with patients who succumbed to the illness. DyNeMo can be used to predict the outcome in a newly diagnosed breast cancer patient and then assist clinicians and patients in making informed decisions on treatment. The study was led by the Mount Sinai Hospital team and co-authored by researchers at the University of Toronto and London, England's The Institute for Cancer Research.

In the future, this tool may be used to analyze other types of cancer and could be used to predict an individual's response to particular drugs.

"This research brings us one step closer to delivering individualized medicine in which healthcare professionals will be able to provide more accurate and personalized diagnoses and treatments," said Dr. Jim Woodgett, Director of Research for the Samuel Lunenfeld Research Institute of Mount Sinai Hospital.

The research was funded by Genome Canada with funds from Ontario Genomics Institute, and the Canadian Breast Cancer Foundation (CBCF) - Ontario Region. The CBCF's Interim CEO Beth Easton said the Foundation, "is pleased to play a role, along with others, in supporting the basic science behind this exciting development for breast cancer patients."

To bring this technology to patients, Mount Sinai Hospital is working to partner with the biotechnology industry, and estimates that the tool will be available to healthcare providers within the next five years.

Source: Samuel Lunenfeld Research Institute

Explore further: Study reveals high–cholesterol diet increases spread of prostate cancer

Related Stories

Live-streaming apps dominate buzz at South by Southwest

Mar 15, 2015

A live-streaming app called Meerkat, calls to online activism and pedicabs with a "Game of Thrones" Iron throne seat were the top topics of conversation at South by Southwest over the weekend, as 33,000-plus ...

ResearchKit: 5 things to know about Apple's medical apps

Mar 11, 2015

Amid all the talk of Apple Watch, a new MacBook laptop and a partnership with HBO, a set of Apple tools aimed at promoting medical research didn't get much attention. The tools, called ResearchKit, promise ...

New nanodevice defeats drug resistance

Mar 02, 2015

Chemotherapy often shrinks tumors at first, but as cancer cells become resistant to drug treatment, tumors can grow back. A new nanodevice developed by MIT researchers can help overcome that by first blocking ...

Recommended for you

Breast cancer is not one disease, experts say

14 hours ago

(HealthDay)—Breast cancer isn't the same for every woman, even at the cellular level, according to a new statement from four major medical groups focused on the disease.

Teens with breast lumps may be able to avoid invasive biopsy

16 hours ago

If a lump is found in the breast of an adolescent girl, she often will undergo an excisional biopsy. However, breast cancer is rare in adolescents, and the vast majority of teenage breast lumps turn out to be benign masses ...

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

thematrix606
not rated yet Feb 02, 2009
Good job, keep the strong work going!
E_L_Earnhardt
not rated yet Feb 02, 2009
Biochemicals seldom if EVER cure a cancer! I put my trust in the SURGEON! CRYOBLATION, where feasable, ALWAYS works, and a "Modified Cyroablation" is the wave of the future! A modified "Accupuncture Program"
(with cold needles) shows promise! X-ray? Not ME!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.